Today: 4 June 2026
RELX PLC reiterates 2026 growth outlook as AI fears keep pressure on shares
6 March 2026
2 mins read

RELX PLC reiterates 2026 growth outlook as AI fears keep pressure on shares

London, March 6, 2026, 09:00 GMT

RELX PLC stuck to its 2026 growth targets in a March investor deck published Thursday, pointing to wider adoption of artificial intelligence in its product lineup as a driver for both customer value and profits. The latest update, posted after a tough stretch for legal and data names, keeps the FTSE 100 information company pressing its advantage.

The question hanging over RELX right now: will generative AI shore up the company’s businesses, or undercut them? The past month has seen investors wrestling with that. Back in early February, Reuters highlighted how Anthropic’s legal AI tools helped spark a wave of selling in RELX, along with Thomson Reuters and Wolters Kluwer. Yet Thursday saw RELX claw back 2.74%, ending the session at 2,623 pence. The FTSE 100 dropped 1.45%.

The slide deck stuck to RELX’s usual script, forecasting “another year of strong underlying growth” for both revenue and adjusted operating profit. Here, “underlying” backs out currency moves and select portfolio shifts. The deck confirmed 2025 revenue guidance at 9.59 billion pounds, with adjusted operating profit pinned at 3.342 billion pounds, and called for 10% constant-currency growth in adjusted earnings per share. Chief Executive Erik Engstrom pointed to AI, saying it’s set to be “a key driver of customer value and growth in our business for many years to come.” Relx

February’s numbers back up management’s favored narrative. Risk, the top division at RELX, delivered 2025 revenue of 3.485 billion pounds, notching 8% underlying growth. Legal climbed 9%, lifted by the likes of Lexis+ AI and Protégé—AI-powered offerings that drove robust renewals and fresh sales across major segments, according to the company.

RELX highlighted new product moves within its faster-growing segments. On March 5, LexisNexis Risk Solutions announced it’s bringing expanded identity verification tools to the Epic Connection Hub used by U.S. hospitals. Next up: adding IDVerse, an AI-driven system built to spot deepfakes, document forgeries, and other types of fraud.

“Striking a balance between user experience and security is critical in an industry that’s still a prime target for cybercrime,” Jonathan Shannon, AVP of healthcare strategy at LexisNexis Risk Solutions, said in the announcement. LexisNexis Risk Solutions

Not everyone’s convinced this rally makes sense. On March 5, Morningstar’s Rob Hales said, “We still view Thomson, RELX, and Wolters stock as undervalued,” and pointed to “heavy pessimism about the sector” already baked into current prices. Morningstar, Inc.

But the risk hasn’t disappeared. Reuters noted last month that Anthropic’s debut erased value from software and professional-services shares, and this week Goldman Sachs executive Mahesh Saireddy flagged that AI-related uncertainty is making lending decisions trickier. For RELX, the fundamental question lingers: can proprietary data and deeply integrated workflows defend pricing power, or will faster-moving, AI-native newcomers take the lead?

RELX hasn’t let up on cash returns as it continues to push its case. In February, the company outlined a 2.25 billion pound buyback for 2026, followed by a proposed final dividend of 48.0 pence per share. The annual meeting is set for April 23.

Thursday’s bounce didn’t close the gap—shares are still trading roughly 37% under their 52-week high. Investors remain unconvinced; RELX needs to show it can pivot the AI story from risk to real, lasting growth.

Stock Market Today

  • Morgan Stanley Raises UnitedHealth Price Target to $453, Maintains Overweight Rating
    June 4, 2026, 10:25 AM EDT. Morgan Stanley increased its price target for UnitedHealth Group (UNH) to $453 from $395 while maintaining an overweight rating, signaling confidence in the health insurer's stock. Analysts polled by FactSet show an average overweight rating and a mean price target of $404.44. The upward revision reflects optimism about UnitedHealth's growth prospects amid ongoing healthcare demand.

Latest articles

UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure

UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure

4 June 2026
UnitedHealth Group surged 5.7% after Bank of America upgraded the stock to Buy and Morgan Stanley hiked its price target, as Wall Street cited signs of easing medical costs and a favorable second-quarter earnings setup, with shares trading near $398 and the board boosting the quarterly dividend to $2.32, even as a Massachusetts lawsuit poses ongoing risk.
Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

Ciena shares fall after strong results, AI trade takes a hit

4 June 2026
Ciena shares plunged 9.5% premarket to $561.51 despite beating Q2 revenue and profit estimates and raising full-year guidance, as investors—already pricing in an AI-driven boom—found the outlook insufficient; two customers made up 34% of revenue, highlighting risk from concentrated orders and volatile AI-linked demand.
Splash Beverage Stock Climbs — NYSE Details for Traders

Splash Beverage Stock Climbs — NYSE Details for Traders

4 June 2026
Splash Beverage soared 71% to $0.2420 after filing a plan to regain NYSE American compliance, with shares quoted at $0.3650 premarket as investors react to survival efforts amid expired Medterra CBD talks, a sharp revenue drop to $4,224, a $2.14 million loss, and just $381,195 in cash, leaving the company dependent on new deals and financing to avoid delisting.
Intel Shares Drop Even as Tech Climbs—AI Trade Not Enough

Intel Shares Dip Premarket Despite Foxconn AI Deal

4 June 2026
Intel shares slid 3.71% to $108.53 premarket as a new AI partnership with Foxconn failed to offset a chip-sector selloff sparked by Broadcom’s disappointing results; investors face uncertainty as Intel and Foxconn gave no financial details, customer names, or launch timeline for their AI collaboration, raising questions about how soon the deal could boost revenue.
Archer Aviation stock moves up as investors watch for 2026 air-taxi test

Archer Aviation Drops Pre-Market With Cash Burn In Focus

4 June 2026
Archer Aviation shares slid 3.3% pre-market to $6.53 as investors weighed heavy quarterly losses and rising cash needs for certification, testing, and manufacturing, despite progress on FAA milestones; the company warned it may need more capital on poor terms if costs rise or development delays, leaving the stock exposed to regulatory and financial risks.
British American Tobacco p.l.c. Faces Fresh UK Shareholder Lawsuit Over North Korea Sanctions Fallout
Previous Story

British American Tobacco p.l.c. Faces Fresh UK Shareholder Lawsuit Over North Korea Sanctions Fallout

GSK steps up share buyback as fresh annual report spells out CEO Luke Miels’ 2026 priorities
Next Story

GSK steps up share buyback as fresh annual report spells out CEO Luke Miels’ 2026 priorities

Go toTop